On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
42° Feels Like: 35°
Wind: WNW 14 mph Past 24 hrs - Precip: 0.24”
Current Radar for Zip

Tonight

Rain 40°

Tomorrow

PM Showers 59°

Fri Night

Mostly Clear 34°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

AstraZeneca's diabetes drug Xigduo approved in Europe

LONDON (Reuters) - AstraZeneca said European regulators had approved Xigduo for type 2 diabetes, in what was the first green light for a fixed dose combination of a SGLT2 inhibitor and metformin.

The drug combines in a twice daily tablet Forxiga, a SGLT2 inhibitor that reduces the reabsorption of excess glucose, and metformin, a standard in treating the condition.

Xigduo was developed by the alliance in diabetes therapy between the British company and Bristol-Myers Squibb, the companies said on Wednesday. AstraZeneca will take full control of the unit later this quarter.

(Reporting by Paul Sandle; editing by Sarah Young)

Comments